Sustained broad-spectrum antibacterial effects of nanoliposomes loaded with silver nanoparticles

Nanomedicine

Volumn 9, Issue 9, 2014, Pages 1301-1310

  Eid, Kamel A M ^a   Azzazy, Hassan M E ^a  

^a The American University in Cairo   (Egypt)

Author keywords

antibacterial effect; broad spectrum; liposome; silver nanoparticle; sustained release

Indexed keywords

ANTIINFECTIVE AGENT; GLUCOSE; LIPOSOME; SILVER NANOPARTICLE; SILVER NITRATE; DELAYED RELEASE FORMULATION; DRUG CARRIER; METAL NANOPARTICLE; SILVER;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; ENCAPSULATION; ESCHERICHIA COLI; EVAPORATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; PROCEDURES; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA; STAPHYLOCOCCUS AUREUS; SUSTAINED DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; WOUND HEALING; ANIMAL; DELAYED RELEASE FORMULATION; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; NANOMEDICINE; PARTICLE SIZE; ULTRASTRUCTURE;

ANIMALS; ANTI-BACTERIAL AGENTS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; ESCHERICHIA COLI; HUMANS; LIPOSOMES; METAL NANOPARTICLES; MICROBIAL SENSITIVITY TESTS; NANOMEDICINE; PARTICLE SIZE; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA; SILVER; STAPHYLOCOCCUS AUREUS;

EID: 84907030253     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.13.89     Document Type: Article

References (33)

1. Liao H, Nehl CL, Hafner JH. Biomedical applications of plasmon resonant metal nanoparticles. Nanomedicine 1(2), 201-208 (2006
2. Chen M, Yang Z, Wu H, Pan X, Xie X, Wu C. Antimicrobial activity and the mechanism of silver nanoparticle thermosensitive gel. Int. J. Nanomedicine 6, 2873-2877 (2011
3. Salem HF, Eid KAM, Sharaf MA. Formulation and evaluation of silver nanoparticles as antibacterial and antifungal agents with a minimal cytotoxic effect. Int. J. Drug Deliv. 3(2), 293-304 (2011
4. Wright GD. Bacterial resistance to antibiotics: enzymatic degradation and modification. Adv. Drug Deliv. Rev. 57(10), 1451-1470 (2005
5. Ghosh S, Patil S, Ahire M et al. Synthesis of silver nanoparticles using Dioscorea bulbifera tuber extract and evaluation of its synergistic potential in combination with antimicrobial agents. Int. J. Nanomedicine 7, 483-496 (2012
6. Kemp MM, Kumar A, Clement D, Ajayan P, Mousa S, Linhardt RJ. Hyaluronan- and heparin-reduced silver nanoparticles with antimicrobial properties. Nanomedicine 4(4), 421-429 (2009
7. Shameli K, Ahmad MB, Zargar M et al. Synthesis and characterization of silver/montmorillonite/chitosan bionanocomposites by chemical reduction method and their antibacterial activity. Int. J. Nanomedicine 6, 271-284 (2011
8. Lara HH, Ayala-Nuñez NV, Ixtepan-Turrent L, Rodriguez- Padilla C. Mode of antiviral action of silver nanoparticles against HIV-1. J. Nanobiotechnology 8(1), 1-10 (2010
9. Rai M, Yadav A, Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnol. Adv. 27(1), 76-83 (2009
10. Pal S, Tak YK, Song JM. Does the antibacterial activity of silver nanoparticles depend on the shape of the nanoparticle? A study of the Gram-negative bacterium Escherichia coli. App. Environ. Microbiol. 73(6), 1712-1720 (2007
11. Eid KAM, Azzazy HME. Controlled synthesis and characterization of hollow flower-like silver nanostructures. Int. J. Nanomedicine 7, 1543-1550 (2012
12. Mugabe C, Halwani M, Azghani AO, Lafrenie RM, Omri A. Mechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 50(6), 2016-2022 (2006
13. Shehata T, Ogawara K, Higaki K, Kimura T. Prolongation of residence time of liposome by surface-modification with mixture of hydrophilic polymers. Int. J. Pharmaceut. 359(1), 272-279 (2008
14. Petros RA, Desimone JM. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 9(8), 615-627 (2010
15. Schwendener RA. Liposomes in biology and medicine. Bioappl. Nanopart. 620, 117-128 (2007
16. Mackinnon N, Guérin G, Liu B, Gradinaru CC, Rubinstein JL, Macdonald PM. Triggered instability of liposomes bound to hydrophobically modified core-shell PNIPAM hydrogel beads. Langmuir 26(2), 1081-1089 (2009
17. Lee SM, Chen H, Dettmer CM, O'Halloran TV, Nguyen SBT. Polymer-caged lipsomes: a pH-responsive delivery system with high stability. J. Am. Chem. Soc. 129(49), 15096-15097 (2007
18. Pornpattananangkul D, Zhang L, Olson S et al. Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. J. Am. Chem. Soc. 33(11), 4132-4139 (2011
19. Savarala S, Monson F, Ilies MA, Wunder SL. Supported lipid bilayer nanosystems. Stabilization by undulatory-protrusion forces and destabilization by lipid bridging. Langmuir 27(10), 5850-5861 (2011
20. Ge L, Möhwald H, Li J. Phospholipid liposomes stabilized by the coverage of polyelectrolyte. Colloids Surf. A Physicochem. Eng. Asp. 221(1-3), 49-53 (2003
21. Bothun GD. Hydrophobic silver nanoparticles trapped in lipid bilayers. Size distribution, bilayer phase behavior, and optical properties. J. Nanobiotechnol. 6(1), 13 (2008
22. Barani H, Montazer M, Toliyat T, Samadi N. Synthesis of Ag-liposome nano composites. J. Liposome Res. 20(4), 323-329 (2010
23. Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat. Nanotechnol. 2(12), 751-760 (2007
24. Schroeder A, Avnir Y, Weisman S et al. Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility. Langmuir 23(7), 4019-4025 (2007
25. Guo X, Szoka FC Jr. Chemical approaches to triggerable lipid vesicles for drug and gene delivery. Acc. Chem. Res. 36(5), 335-341 (2003
26. Raetz CRH, Reynolds CM, Trent MS, Bishop RE. Lipid A modification systems in Gram-negative bacteria. Ann. Rev. Biochem. 76, 295 (2007
27. Li J, Nation RL, Turnidge JD et al. Colistin: the re-emerging antibiotic for multidrug-resistant Gram negative bacterial infections. Lancet Infect. Dis. 6(9), 589-601 (2006
28. Amin RM, Mohamed MB, Ramadan MA, Verwanger T, Krammer B. Rapid and sensitive microplate assay for screening the effect of silver and gold nanoparticles on bacteria. Nanomedicine 4(6), 637-643 (2009
29. Kim JS, Kuk E, Yu KN et al. Antimicrobial effects of silver nanoparticles. Nanomedicine 3(1), 95-101 (2007
30. Li WR, Xie XB, Shi QS, Zeng HY, Ou-Yang YS, Chen YB. Antibacterial activity and mechanism of silver nanoparticles on Escherichia coli. App. Microbiol. Biotechnol. 85(4), 1115-1122 (2010
31. Sondi I, Salopek-Sondi B. Silver nanoparticles as antimicrobial agent. A case study on E. coli as a model for Gram-negative bacteria. J. Colloid Interface Sci. 275(1), 177-182 (2004
32. Lara HH, Ayala-Nuñez NV, Ixtepan-Turrent L, Rodriguez- Padilla C. Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria. World J. Microbiol. Biotechnol. 26(4), 615-621 (2010
33. Pagès JM, James CE, Winterhalter M. The porin and the permeating antibiotic. A selective diffusion barrier in Gram-negative bacteria. Nat. Rev. Microbiol. 6(12), 893-903 (2008